2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 4 of 4 drug pricing articles
CAR-T Therapy Cost in 2025: Why It's $475,000 and What You'll Actually Pay - 2026 Drug Cost Analysis

CAR-T Therapy Cost in 2025: Why It's $475,000 and What You'll Actually Pay

24 views

Wondering how much CAR-T therapy really costs in 2025? The sticker price is $475,000—but most patients pay $2,000 to $15,000 thanks to insurance, Medicare, and patient assistance programs. Here's exactly what you'll pay and how uninsured patients are getting this life-saving treatment for free.

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update) - 2026 Drug Cost Analysis

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update)

146 views

CAR-T cell therapy remains one of the most promising yet expensive cancer treatments in 2026. This detailed guide explains whether insurance companies in the U.S. — including Medicare, Medicaid, and private plans — cover CAR-T therapy. We also include updated treatment prices, hospital billing comparisons, and available financial assistance options to help patients manage costs.

CAR-T Therapy Cost in 2026: How Much Does It Really Cost in the U.S.? - 2026 Drug Cost Analysis

CAR-T Therapy Cost in 2026: How Much Does It Really Cost in the U.S.?

171 views

CAR-T therapy is transforming cancer treatment—but its cost remains among the highest in modern medicine. In 2026, total U.S. treatment expenses often range from $500,000 to over $1 million, depending on hospital, insurance coverage, and side-effect management. This guide breaks down updated CAR-T therapy prices, real-world cost data, insurance options, and expert forecasts for future affordability. Learn how patients can prepare financially and explore assistance programs that make this life-saving therapy more accessible.

Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update) - 2026 Drug Cost Analysis

Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update)

610 views

In 2025, cancer treatment costs in the United States remain among the highest in the world, with several oncology drugs carrying annual price tags well over $150,000. This article breaks down the Top 10 most expensive cancer drugs in the U.S., comparing per-dose and per-year costs, highlighting manufacturers, and explaining what patients actually pay after insurance. From blockbuster immunotherapies like Keytruda and Imfinzi to groundbreaking CAR-T and gene therapies priced at nearly half a million dollars per treatment, this guide provides a clear look at the latest pricing landscape and practical insights for patients navigating financial support programs.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings